All 9 /Events 0 /In The News 8 /Press Releases 1

NRG Therapeutics CEO Spotlight Video SBC

NRG Therapeutics CEO Spotlight Video SBC
Watch now
27 March 2026/by Webadm

Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation

SCRIP

Read more
6 February 2026/by Webadm

Founder-CEO Interview Series

Sejelas

Read more
28 January 2026/by Webadm

Disease-modifying treatment for ALS enters Phase I

Drug Discovery World

Read more
26 January 2026/by Webadm

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

Target ALS

Read more
26 January 2026/by Webadm

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial – Target ALS

ALS News Today

Read more
16 January 2026/by Webadm

NRG doses first volunteers in mitochondrial ALS trial

Longevity Technology

Read more
9 January 2026/by Webadm

NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s

Stevenage, UK, 8 January 2026 - NRG Therapeutics Ltd. (“NRG”),…
8 January 2026/by Webadm

Michael J Fox Foundation adviser joins NRG Therapeutics

Business Weekly

Read more
2 December 2025/by Webadm

My Name’5 Doddie Foundation’s Discovery Network Showcase 2026

My Name’5 Doddie Foundation’s Discovery Network Showcase…

ALS Nexus Conference 2026

ALS Nexus Conference 2026 23-26 August 2026 Orlando, US View…

ENCALS European Network to cure ALS meeting 2026

ENCALS European Network to cure ALS meeting 2026 23-26 June…

Bio International Convention

Bio International Convention 22-25 June 2026 San Diego, USA View…

Target ALS Annual meeting

Target ALS Annual meeting 5-7 May 2026 Boston, USA View…

NEALS Workshop on Advancing ALS Clinical Trials

NEALS Workshop on Advancing ALS Clinical Trials 9 April 2026 Cambridge,…

NRG Therapeutics CEO Spotlight Video SBC

NRG Therapeutics CEO Spotlight Video SBC Watch now

BioEurope Spring

BioEurope Spring 23-25 March 2026 Lisbon, Portugal View…

AD/PD™ 2026 Advances In Science & Therapy

AD/PD™ 2026 Advances In Science & Therapy 17-21 March…